Pulmonary embolism differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{| class="infobox" style="float:right;"
{| class="infobox" style="float:right;"
|-
|-
| [[File:Siren.gif|30px|link=Pulmonary embolism resident survival guide]]|| <br> || <br>
| <figure-inline>[[File:Siren.gif|link=Pulmonary embolism resident survival guide|41x41px]]</figure-inline>|| <br> || <br>
| [[Pulmonary embolism resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
| [[Pulmonary embolism resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
|}
Line 13: Line 13:
==Differential Diagnosis==
==Differential Diagnosis==
===Differential Diagnosis Based on Symptoms===
===Differential Diagnosis Based on Symptoms===
Pulmonary embolism (PE) should be differentiated from other diseases presenting with chest pain, shortness of breath and tachypnea. The differentials include the following:
Pulmonary embolism (PE) should be differentiated from other diseases presenting with [[chest pain]], [[shortness of breath]] and [[tachypnea]]. The differentials include the following:
<small>
<small>
{|
{|
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
Line 56: Line 56:
| style="background: #F5F5F5; padding: 5px;" |✔ (In case of massive PE)
| style="background: #F5F5F5; padding: 5px;" |✔ (In case of massive PE)
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Hypercoagulating conditions (Factor V Leiden, thrombophilia, deep vein thrombosis, immobilization, malignancy, pregnancy)
*Hypercoagulating conditions (Factor V Leiden, thrombophilia, deep vein thrombosis, immobilization, malignancy, pregnancy)
Line 66: Line 66:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Congestive heart failure]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Congestive heart failure]]
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*On CT scan:
*On CT scan:
** Mediastinal lymphadenopathy
** Mediastinal lymphadenopathy
Line 74: Line 74:
** Delayed enhancement MRI may help characterize the myocardial tissue (fibrosis)
** Delayed enhancement MRI may help characterize the myocardial tissue (fibrosis)
** Late enhancement of contrast in conditions such as myocarditis, sarcoidosis, amyloidoisis, Anderson-Fabry's disease, Chagas' disease)
** Late enhancement of contrast in conditions such as myocarditis, sarcoidosis, amyloidoisis, Anderson-Fabry's disease, Chagas' disease)
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity)
*Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity)
**SV1 or SV2 + RV5 or RV6 ≥3.5 mV
**SV1 or SV2 + RV5 or RV6 ≥3.5 mV
**Total QRS amplitude in each of the limb leads ≤0.8 mV
**Total QRS amplitude in each of the limb leads ≤0.8 mV
** R/S ratio <1 in lead V4
** R/S ratio <1 in lead V4
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Cardiomegaly
*Cardiomegaly
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Previous myocardial infarction
*Previous myocardial infarction
Line 107: Line 107:
**Eventual right heart faliure
**Eventual right heart faliure
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Percarditis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Percarditis]]
|style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*On contrast enhanced CT scan:
*On contrast enhanced CT scan:
**Enhancement of the pericardium (due to inflammation)
**Enhancement of the pericardium (due to inflammation)
Line 116: Line 116:
**Pericardial enhancement (due to inflammation)
**Pericardial enhancement (due to inflammation)
**Pericardial effusion
**Pericardial effusion
|style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*ST elevation
*ST elevation
*PR depression
*PR depression
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Large collection of fluid inside the pericardial sac (pericardial effusion)
*Large collection of fluid inside the pericardial sac (pericardial effusion)
*Calcification of pericardial sac
*Calcification of pericardial sac
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔ (Low grade)
| style="background: #F5F5F5; padding: 5px;" |✔ (Low grade)
|style="background: #F5F5F5; padding: 5px;" |✔ (Relieved by sitting up and leaning forward)
| style="background: #F5F5F5; padding: 5px;" |✔ (Relieved by sitting up and leaning forward)
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Infections:
*Infections:
**Viral (Coxsackie virus, Herpes virus, Mumps virus, HIV)
**Viral (Coxsackie virus, Herpes virus, Mumps virus, HIV)
Line 142: Line 142:
*Malignancy
*Malignancy
*Previous myocardial infarction
*Previous myocardial infarction
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*May be clinically classified into:
*May be clinically classified into:
**Acute (< 6 weeks)
**Acute (< 6 weeks)
Line 148: Line 148:
**Chronic (> 6 months)
**Chronic (> 6 months)
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pneumonia]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pneumonia]]
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
**On CT scan: (not generally indicated)
**On CT scan: (not generally indicated)
*Consolidation (alveolar/lobar pneumonia)
*Consolidation (alveolar/lobar pneumonia)
Line 158: Line 158:
**On MRI:
**On MRI:
*Not indicated
*Not indicated
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Prolonged PR interval  
*Prolonged PR interval  
*Transient T wave inversions
*Transient T wave inversions
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Consolidation (alveolar/lobar pneumonia)
*Consolidation (alveolar/lobar pneumonia)
*Peribronchial nodules (bronchopneumonia)
*Peribronchial nodules (bronchopneumonia)
*Ground-glass opacity (GGO)
*Ground-glass opacity (GGO)
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Ill-contact
*Ill-contact
*Travelling
*Travelling
Line 182: Line 182:
*Recent hospitalization
*Recent hospitalization
*Chronic obstructive pulmonary disease
*Chronic obstructive pulmonary disease
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Requires sputum stain and culture for diagnosis
*Requires sputum stain and culture for diagnosis
*Empiric management usually started before culture results
*Empiric management usually started before culture results
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vasculitis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vasculitis]]
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*On CT scan: (Takayasu arteritis)
*On CT scan: (Takayasu arteritis)
**Vessel wall thickening
**Vessel wall thickening
Line 194: Line 194:
*On MRI:
*On MRI:
Homogeneous, circumferential vessel wall swelling  
Homogeneous, circumferential vessel wall swelling  
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Right or left bundle-branch block (Churg-Strauss syndrome)
*Right or left bundle-branch block (Churg-Strauss syndrome)
*Atrial fibrillation (Churg-Strauss syndrome)
*Atrial fibrillation (Churg-Strauss syndrome)
*Non-specific ST segment and T wave changes  
*Non-specific ST segment and T wave changes  
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Nodules
*Nodules
*Cavitation
*Cavitation
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Takayasu arteritis usually found in persons aged 4-60 years with a mean of 30
*Takayasu arteritis usually found in persons aged 4-60 years with a mean of 30
*Giant-cell arteritis usually occurrs in persons aged > 60 years
*Giant-cell arteritis usually occurrs in persons aged > 60 years
*Churg-Strauss syndrome may present with asthma, sinusitis, transient pulmonary infiltrates and neuropathy alongwith cardiac involvement
*Churg-Strauss syndrome may present with asthma, sinusitis, transient pulmonary infiltrates and neuropathy alongwith cardiac involvement
*Granulomatous vasculitides may present with nephtitis and upper airway (nasopharyngeal) destruction
*Granulomatous vasculitides may present with nephtitis and upper airway (nasopharyngeal) destruction
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chronic obstructive pulmonary disease]] (COPD)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Chronic obstructive pulmonary disease]] (COPD)
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*On CT scan:
*On CT scan:
**Chronic bronchitis may show bronchial wall thickening, scarring with bronchovascular irregularity, fibrosis
**Chronic bronchitis may show bronchial wall thickening, scarring with bronchovascular irregularity, fibrosis
Line 229: Line 229:
**Loss of retrosternal airspace due to right ventricular enlargement
**Loss of retrosternal airspace due to right ventricular enlargement
**Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung
**Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Multifocal atrial tachycardia (atleast 3 distinct P wave morphologies)
*Multifocal atrial tachycardia (atleast 3 distinct P wave morphologies)
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Enlarged lung shadows (emphysema)
*Enlarged lung shadows (emphysema)
*Flattening of diaphragm (emphysema)
*Flattening of diaphragm (emphysema)
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Smoking
*Smoking
*Alpha-1 antitrypsin deficiency
*Alpha-1 antitrypsin deficiency
*Increased sputum production (chronic bronhitis)
*Increased sputum production (chronic bronhitis)
*Cough
*Cough
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Alpha 1 antitrypsin deficiency may be associated with hepatomegaly
*Alpha 1 antitrypsin deficiency may be associated with hepatomegaly
|}
|}

Revision as of 20:41, 13 October 2017

<figure-inline></figure-inline>

Resident
Survival
Guide

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism differential diagnosis

CDC on Pulmonary embolism differential diagnosis

Pulmonary embolism differential diagnosis in the news

Blogs on Pulmonary embolism differential diagnosis

Directions to Hospitals Treating Pulmonary embolism differential diagnosis

Risk calculators and risk factors for Pulmonary embolism differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] The APEX Trial Investigators; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Pulmonary embolism must be distinguished from other life-threatening causes of chest pain including acute myocardial infarction, aortic dissection, and pericardial tamponade, as well as a large list of non-life-threatening causes of chest discomfort and shortness of breath.

Differential Diagnosis

Differential Diagnosis Based on Symptoms

Pulmonary embolism (PE) should be differentiated from other diseases presenting with chest pain, shortness of breath and tachypnea. The differentials include the following:

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT scan and MRI EKG Chest X-ray Tachypnea Tachycardia Fever Chest Pain Hemoptysis Dyspnea on Exertion Wheezing Chest Tenderness Nasalopharyngeal Ulceration Carotid Bruit
Pulmonary embolism
  • On CT angiography:
    • Intra-luminal filling defect
  • On MRI:
    • Narrowing of involved vessel
    • No contrast seen distal to obstruction
    • Polo-mint sign (partial filling defect surrounded by contrast)
  • S1Q3T3 pattern representing acute right heart strain
  • Fleischner sign (enlarged pulmonary artery), Hampton hump, Westermark's sign
✔ (Low grade) ✔ (In case of massive PE) - - - -
  • Hypercoagulating conditions (Factor V Leiden, thrombophilia, deep vein thrombosis, immobilization, malignancy, pregnancy)
  • May be associated with metabolic alkalosis and syncope
Congestive heart failure
  • On CT scan:
    • Mediastinal lymphadenopathy
    • hazy mediastinal fat
  • On MRI:
    • Abnormality of cardiac chambers (hypertrophy, dilation)
    • Delayed enhancement MRI may help characterize the myocardial tissue (fibrosis)
    • Late enhancement of contrast in conditions such as myocarditis, sarcoidosis, amyloidoisis, Anderson-Fabry's disease, Chagas' disease)
  • Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity)
    • SV1 or SV2 + RV5 or RV6 ≥3.5 mV
    • Total QRS amplitude in each of the limb leads ≤0.8 mV
    • R/S ratio <1 in lead V4
  • Cardiomegaly
- - - - - -
  • Previous myocardial infarction
  • Hypertension (systemic and pulmonary)
  • Cardiac arrythmias
  • Viral infections (myocarditis)
  • Congenital heart defects
  • Right heart faliure ssociated with:
    • Hepatomegaly
    • Positive hepatojugular reflex
    • Increased jugular venous pressure
    • Peripheral edema
  • Left heart faliure associated with:
    • Pulmonary edema
    • Eventual right heart faliure
Percarditis
  • On contrast enhanced CT scan:
    • Enhancement of the pericardium (due to inflammation)
    • Pericardial effusion
    • Pericardial calcification
  • On gadolinium-enhanced fat-saturated T1-weighted MRI:
    • Pericardial enhancement (due to inflammation)
    • Pericardial effusion
  • ST elevation
  • PR depression
  • Large collection of fluid inside the pericardial sac (pericardial effusion)
  • Calcification of pericardial sac
✔ (Low grade) ✔ (Relieved by sitting up and leaning forward) - - - - -
  • Infections:
    • Viral (Coxsackie virus, Herpes virus, Mumps virus, HIV)
    • Bacteria (Mycobacterium tuberculosis-common in developing countries)
    • Fungal (Histoplasmosis)
  • Idiopathic in a large number of cases
  • Autoimmune
  • Uremia
  • Malignancy
  • Previous myocardial infarction
  • May be clinically classified into:
    • Acute (< 6 weeks)
    • Sub-acute (6 weeks - 6 months)
    • Chronic (> 6 months)
Pneumonia
    • On CT scan: (not generally indicated)
  • Consolidation (alveolar/lobar pneumonia)
  • Peribronchial nodules (bronchopneumonia)
  • Ground-glass opacity (GGO)
  • Abscess
  • Pleural effusion
    • On MRI:
  • Not indicated
  • Prolonged PR interval
  • Transient T wave inversions
  • Consolidation (alveolar/lobar pneumonia)
  • Peribronchial nodules (bronchopneumonia)
  • Ground-glass opacity (GGO)
- - - -
  • Ill-contact
  • Travelling
  • Smoking
  • Diabetic
  • Recent hospitalization
  • Chronic obstructive pulmonary disease
  • Requires sputum stain and culture for diagnosis
  • Empiric management usually started before culture results
Vasculitis
  • On CT scan: (Takayasu arteritis)
    • Vessel wall thickening
    • Luminal narrowing of pulmonary artery
    • Masses or nodules (ANCA-associated granulomatous vasculitis)
  • On MRI:

Homogeneous, circumferential vessel wall swelling

  • Right or left bundle-branch block (Churg-Strauss syndrome)
  • Atrial fibrillation (Churg-Strauss syndrome)
  • Non-specific ST segment and T wave changes
  • Nodules
  • Cavitation
-
  • Takayasu arteritis usually found in persons aged 4-60 years with a mean of 30
  • Giant-cell arteritis usually occurrs in persons aged > 60 years
  • Churg-Strauss syndrome may present with asthma, sinusitis, transient pulmonary infiltrates and neuropathy alongwith cardiac involvement
  • Granulomatous vasculitides may present with nephtitis and upper airway (nasopharyngeal) destruction
Chronic obstructive pulmonary disease (COPD)
  • On CT scan:
    • Chronic bronchitis may show bronchial wall thickening, scarring with bronchovascular irregularity, fibrosis
    • Emphysema may show alveolar septal destruction and airspace enlargement (Centrilobular- upper lobe, panlobular- lower lobe)
    • Giant bubbles
  • ON MRI:
    • Increased diameter of pulmonary arteries
    • Peripheral pulmonary vasculature attentuation
    • Loss of retrosternal airspace due to right ventricular enlargement
    • Hyperpolarized Helium MRI may show progressively poor ventilation and destruction of lung
  • Multifocal atrial tachycardia (atleast 3 distinct P wave morphologies)
  • Enlarged lung shadows (emphysema)
  • Flattening of diaphragm (emphysema)
- - - - - -
  • Smoking
  • Alpha-1 antitrypsin deficiency
  • Increased sputum production (chronic bronhitis)
  • Cough
  • Alpha 1 antitrypsin deficiency may be associated with hepatomegaly

Life Threatening Differential Diagnosis

Common Differential Diagnosis in Outpatients

Among outpatients presenting with dyspnea, <4 % are diagnosed with PE.[1] Common differential diagnoses include:[1]

Complete List of Differential Diagnosis

References

  1. 1.0 1.1 1.2 1.3 1.4 Squizzato A, Luciani D, Rubboli A, Di Gennaro L, Gennaro LD, Landolfi R; et al. (2013). "Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms". Intern Emerg Med. 8 (8): 695–702. doi:10.1007/s11739-011-0725-1. PMID 22094406.
  2. Restrepo CS, Artunduaga M, Carrillo JA, Rivera AL, Ojeda P, Martinez-Jimenez S; et al. (2009). "Silicone pulmonary embolism: report of 10 cases and review of the literature". J Comput Assist Tomogr. 33 (2): 233–7. doi:10.1097/RCT.0b013e31817ecb4e. PMID 19346851.

Template:WH Template:WS